{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:28:52Z","timestamp":1785338932001,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11481-023-10068-9","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T08:02:01Z","timestamp":1686902521000},"page":"383-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ibrutinib Delays ALS Installation and Increases Survival of SOD1G93A Mice by Modulating PI3K\/mTOR\/Akt Signaling"],"prefix":"10.1007","volume":"18","author":[{"given":"Chengyou","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"4","key":"10068_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040620714539906","volume":"5","author":"A Aalipour","year":"2014","unstructured":"Aalipour A, Advani RH (2014) Bruton\u2019s tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib. Ther Adv Hematol 5(4):121\u2013133. https:\/\/doi.org\/10.1177\/2040620714539906","journal-title":"Ther Adv Hematol"},{"issue":"8","key":"10068_CR2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3109\/10428194.2013.796049","volume":"54","author":"J Barrientos","year":"2013","unstructured":"Barrientos J, Rai K (2013) Ibrutinib: a novel Bruton\u2019s tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia. Leuk Lymphoma 54(8):1817\u20131820. https:\/\/doi.org\/10.3109\/10428194.2013.796049","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10068_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molmed.2004.06.009","volume":"10","author":"C Bendotti","year":"2004","unstructured":"Bendotti C, Carr\u00ec MT (2004) Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10(8):393\u2013400. https:\/\/doi.org\/10.1016\/j.molmed.2004.06.009","journal-title":"Trends Mol Med"},{"issue":"3","key":"10068_CR4","first-page":"325","volume":"9","author":"A Calvo","year":"2010","unstructured":"Calvo A, Moglia C, Balma M, Chio A (2010) Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity? CNS & neurological Disorders-Drug targets (formerly current drug Targets-CNS &amp. Neurol Disorders) 9(3):325\u2013330","journal-title":"Neurol Disorders)"},{"issue":"7","key":"10068_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cne.23917","volume":"524","author":"LH Comley","year":"2016","unstructured":"Comley LH, Nijssen J, Frost-Nylen J, Hedlund E (2016) Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. J Comp Neurol 524(7):1424\u20131442. https:\/\/doi.org\/10.1002\/cne.23917","journal-title":"J Comp Neurol"},{"issue":"1","key":"10068_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10020-018-0069-7","volume":"25","author":"AP de Porto","year":"2019","unstructured":"de Porto AP, Liu Z, de Beer R, Florquin S, de Boer OJ, Hendriks RW, de Vos AF (2019) Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. Mol Med 25(1):3. https:\/\/doi.org\/10.1186\/s10020-018-0069-7","journal-title":"Mol Med"},{"issue":"5","key":"10068_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2990.2007.00850.x","volume":"33","author":"M Dewil","year":"2007","unstructured":"Dewil M, Lambrechts D, Sciot R, Shaw PJ, Ince PG, Robberecht W, Van den Bosch L (2007) Vascular endothelial growth factor counteracts the loss of phospho-akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 33(5):499\u2013509. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00850.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10068_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","volume":"8","author":"G Dobrowolny","year":"2008","unstructured":"Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Musar\u00f2 A (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8(5):425\u2013436. https:\/\/doi.org\/10.1016\/j.cmet.2008.09.002","journal-title":"Cell Metab"},{"issue":"5","key":"10068_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Godbout JP (2014) Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis. Neuron 81(5):1009\u20131023","journal-title":"Neuron"},{"issue":"4","key":"10068_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00280-018-3546-3","volume":"81","author":"L Goldwirt","year":"2018","unstructured":"Goldwirt L, Beccaria K, Ple A, Sauvageon H, Mourah S (2018) Ibrutinib brain distribution: a preclinical study. Cancer Chemother Pharmacol 81(4):783\u2013789. https:\/\/doi.org\/10.1007\/s00280-018-3546-3","journal-title":"Cancer Chemother Pharmacol"},{"issue":"16","key":"10068_CR12","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/hmg\/ddy204","volume":"27","author":"D Gonzalez","year":"2018","unstructured":"Gonzalez D, Rebolledo DL, Correa LM, Court FA, Cerpa W, Lipson KE, Brandan E (2018) The inhibition of CTGF\/CCN2 activity improves muscle and locomotor function in a murine ALS model. Hum Mol Genet 27(16):2913\u20132926. https:\/\/doi.org\/10.1093\/hmg\/ddy204","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10068_CR13","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1080\/15548627.2021.1899682","volume":"17","author":"V Granatiero","year":"2021","unstructured":"Granatiero V, Sayles NM, Savino AM, Konrad C, Kharas MG, Kawamata H, Manfredi G (2021) Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1(G93A) astrocytes. Autophagy 17(12):4029\u20134042. https:\/\/doi.org\/10.1080\/15548627.2021.1899682","journal-title":"Autophagy"},{"issue":"11\u201312","key":"10068_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.bbadis.2006.01.004","volume":"1762","author":"F Gros-Louis","year":"2006","unstructured":"Gros-Louis F, Gaspar C, Rouleau GA (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta 1762(11\u201312):956\u2013972. https:\/\/doi.org\/10.1016\/j.bbadis.2006.01.004","journal-title":"Biochim Biophys Acta"},{"issue":"5166","key":"10068_CR15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264(5166):1772\u20131775. https:\/\/doi.org\/10.1126\/science.8209258","journal-title":"Science"},{"key":"10068_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejmech.2017.12.079","volume":"145","author":"L He","year":"2018","unstructured":"He L, Pei H, Zhang C, Shao M, Li D, Tang M, Chen L (2018) Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis. Eur J Med Chem 145:96\u2013112. https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.079","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10068_CR17","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Hern\u00e1ndez-Dami\u00e1n J, Pedraza-Chaverri J (2014) The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 26(12):2694\u20132701. https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.019","journal-title":"Cell Signal"},{"issue":"2","key":"10068_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"KG Hooten","year":"2015","unstructured":"Hooten KG, Beers DR, Zhao W, Appel SH (2015) Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics 12(2):364\u2013375. https:\/\/doi.org\/10.1007\/s13311-014-0329-3","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10068_CR19","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin X-Y, Yu Y, Yuan J, Zhao Y, Cheng Y (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7(1):9094. https:\/\/doi.org\/10.1038\/s41598-017-09097-1","journal-title":"Sci Rep"},{"issue":"4","key":"10068_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mus.20949","volume":"37","author":"S Kuwabara","year":"2008","unstructured":"Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, Inaba A, Hatanaka Y (2008) Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 37(4):426\u2013430. https:\/\/doi.org\/10.1002\/mus.20949","journal-title":"Muscle Nerve"},{"issue":"5","key":"10068_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurol.2017.04.003","volume":"173","author":"T Lenglet","year":"2017","unstructured":"Lenglet T, Camdessanch\u00e9 JP (2017) Amyotrophic lateral sclerosis or not: Keys for the diagnosis. Rev Neurol (Paris) 173(5):280\u2013287. https:\/\/doi.org\/10.1016\/j.neurol.2017.04.003","journal-title":"Rev Neurol (Paris)"},{"issue":"49","key":"10068_CR23","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1073\/pnas.1014862107","volume":"107","author":"Q Li","year":"2010","unstructured":"Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, Miller TM (2010) ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A 107(49):21146\u201321151. https:\/\/doi.org\/10.1073\/pnas.1014862107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10068_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.vetmic.2018.10.031","volume":"227","author":"B Li","year":"2018","unstructured":"Li B, Xi P, Wang Z, Han X, Xu Y, Zhang Y, Miao J (2018) PI3K\/Akt\/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs\/NF-\u0138B pathway. Vet Microbiol 227:103\u2013111. https:\/\/doi.org\/10.1016\/j.vetmic.2018.10.031","journal-title":"Vet Microbiol"},{"key":"10068_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F (2017) Role of Neuroinflammation in Amyotrophic lateral sclerosis: Cellular Mechanisms and therapeutic implications. Front Immunol 8:1005. https:\/\/doi.org\/10.3389\/fimmu.2017.01005","journal-title":"Front Immunol"},{"issue":"4","key":"10068_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","volume":"81","author":"G Logroscino","year":"2010","unstructured":"Logroscino G, Traynor BJ, Hardiman O, Chi\u00f2 A, Mitchell D, Swingler RJ, Beghi E (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81(4):385\u2013390. https:\/\/doi.org\/10.1136\/jnnp.2009.183525","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10068_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/wco.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771\u2013776. https:\/\/doi.org\/10.1097\/wco.0000000000000730","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10068_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mus.26289","volume":"59","author":"MS Lyon","year":"2019","unstructured":"Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C (2019) Inflammation, immunity, and amyotrophic lateral sclerosis: I. etiology and pathology. Muscle Nerve 59(1):10\u201322. https:\/\/doi.org\/10.1002\/mus.26289","journal-title":"Muscle Nerve"},{"key":"10068_CR28","doi-asserted-by":"publisher","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E, Gessani A, Fini N, Fasano A, Cossarizza A (2018) Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, doubleblind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Med (Baltim) 97(24):e11119. https:\/\/doi.org\/10.1097\/md.0000000000011119","DOI":"10.1097\/md.0000000000011119"},{"issue":"2","key":"10068_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/bjh.14218","volume":"179","author":"C Mason","year":"2017","unstructured":"Mason C, Savona S, Rini JN, Castillo JJ, Xu L, Hunter ZR, Allen SL (2017) Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. Br J Haematol 179(2):339\u2013341. https:\/\/doi.org\/10.1111\/bjh.14218","journal-title":"Br J Haematol"},{"issue":"2","key":"10068_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.clinph.2012.07.025","volume":"124","author":"P Menon","year":"2013","unstructured":"Menon P, Kiernan MC, Yiannikas C, Stroud J, Vucic S (2013) Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol 124(2):410\u2013416. https:\/\/doi.org\/10.1016\/j.clinph.2012.07.025","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10068_CR31","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1038\/s41598-020-72887-7","volume":"10","author":"YG Min","year":"2020","unstructured":"Min YG, Choi S-J, Hong Y-H, Kim S-M, Shin J-Y, Sung J-J (2020) Dissociated leg muscle atrophy in amyotrophic lateral sclerosis\/motor neuron disease: the \u2018split-leg\u2019 sign. Sci Rep 10(1):15661. https:\/\/doi.org\/10.1038\/s41598-020-72887-7","journal-title":"Sci Rep"},{"key":"10068_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2015.02.017","volume":"77","author":"BJ Murdock","year":"2015","unstructured":"Murdock BJ, Bender DE, Segal BM, Feldman EL (2015) The dual roles of immunity in ALS: injury overrides protection. Neurobiol Dis 77:1\u201312","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10068_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12974-018-1308-0","volume":"15","author":"HY Nam","year":"2018","unstructured":"Nam HY, Nam JH, Yoon G, Lee JY, Nam Y, Kang HJ, Hoe HS (2018) Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. J Neuroinflammation 15(1):271. https:\/\/doi.org\/10.1186\/s12974-018-1308-0","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10068_CR34","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1523\/jneurosci.20-08-02875.2000","volume":"20","author":"K Namikawa","year":"2000","unstructured":"Namikawa K, Honma M, Abe K, Takeda M, Mansur K, Obata T, Kiyama H (2000) Akt\/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 20(8):2875\u20132886. https:\/\/doi.org\/10.1523\/jneurosci.20-08-02875.2000","journal-title":"J Neurosci"},{"key":"10068_CR35","doi-asserted-by":"publisher","unstructured":"Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C (2018) SOD1 in amyotrophic lateral sclerosis: \u201cAmbivalent\u201d behavior connected to the Disease. Int J Mol Sci 19(5). https:\/\/doi.org\/10.3390\/ijms19051345","DOI":"10.3390\/ijms19051345"},{"issue":"9","key":"10068_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrn1971","volume":"7","author":"P Pasinelli","year":"2006","unstructured":"Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7(9):710\u2013723. https:\/\/doi.org\/10.1038\/nrn1971","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10068_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.mcn.2007.01.003","volume":"34","author":"M Peviani","year":"2007","unstructured":"Peviani M, Cheroni C, Troglio F, Quarto M, Pelicci G, Bendotti C (2007a) Lack of changes in the PI3K\/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 34(4):592\u2013602. https:\/\/doi.org\/10.1016\/j.mcn.2007.01.003","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"10068_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.mcn.2007.01.003","volume":"34","author":"M Peviani","year":"2007","unstructured":"Peviani M, Cheroni C, Troglio F, Quarto M, Pelicci G, Bendotti C (2007b) Lack of changes in the PI3K\/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 34(4):592\u2013602. https:\/\/doi.org\/10.1016\/j.mcn.2007.01.003","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10068_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12035-013-8507-6","volume":"49","author":"M Peviani","year":"2014","unstructured":"Peviani M, Tortarolo M, Battaglia E, Piva R, Bendotti C (2014) Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis. Mol Neurobiol 49(1):136\u2013148. https:\/\/doi.org\/10.1007\/s12035-013-8507-6","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10068_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"T Philips","year":"2011","unstructured":"Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10(3):253\u2013263. https:\/\/doi.org\/10.1016\/S1474-4422(11)70015-1","journal-title":"Lancet Neurol"},{"key":"10068_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/b978-0-12-385883-2.00002-3","volume":"107","author":"RL Redler","year":"2012","unstructured":"Redler RL, Dokholyan NV (2012) The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci 107:215\u2013262. https:\/\/doi.org\/10.1016\/b978-0-12-385883-2.00002-3","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"22","key":"10068_CR42","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/nejm200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688\u20131700. https:\/\/doi.org\/10.1056\/nejm200105313442207","journal-title":"N Engl J Med"},{"issue":"45","key":"10068_CR43","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini DM (2017) Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A 114(45):11818\u201311825. https:\/\/doi.org\/10.1073\/pnas.1716173114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10068_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1055\/s-0035-1558984","volume":"35","author":"JS Salameh","year":"2015","unstructured":"Salameh JS, Brown RH Jr, Berry JD (2015) Amyotrophic lateral sclerosis: review. Semin Neurol 35(4):469\u2013476. https:\/\/doi.org\/10.1055\/s-0035-1558984","journal-title":"Semin Neurol"},{"issue":"13","key":"10068_CR45","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/hmg\/ddm110","volume":"16","author":"D Sau","year":"2007","unstructured":"Sau D, De Biasi S, Vitellaro-Zuccarello L, Riso P, Guarnieri S, Porrini M, Poletti A (2007) Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet 16(13):1604\u20131618. https:\/\/doi.org\/10.1093\/hmg\/ddm110","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10068_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuron.2013.07.027","volume":"80","author":"S Saxena","year":"2013","unstructured":"Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, Caroni P (2013) Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80(1):80\u201396. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.027","journal-title":"Neuron"},{"key":"10068_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neuro.2016.03.017","volume":"56","author":"PS Spencer","year":"2016","unstructured":"Spencer PS, Palmer VS, Kisby GE (2016) Seeking environmental causes of neurodegenerative disease and envisioning primary prevention. Neurotoxicology 56:269\u2013283. https:\/\/doi.org\/10.1016\/j.neuro.2016.03.017","journal-title":"Neurotoxicology"},{"issue":"1","key":"10068_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-8-31","volume":"8","author":"KA Staats","year":"2013","unstructured":"Staats KA, Hernandez S, Sch\u00f6nefeldt S, Bento-Abreu A, Dooley J, Van Damme P, Van Den Bosch L (2013) Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol Neurodegeneration 8(1):31. https:\/\/doi.org\/10.1186\/1750-1326-8-31","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"10068_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","volume":"1784","author":"L Swiech","year":"2008","unstructured":"Swiech L, Perycz M, Malik A, Jaworski J (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta 1784(1):116\u2013132. https:\/\/doi.org\/10.1016\/j.bbapap.2007.08.015","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10068_CR50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/wco.0000000000000593","volume":"31","author":"S Vucic","year":"2018","unstructured":"Vucic S, Rutkove SB (2018) Neurophysiological biomarkers in amyotrophic lateral sclerosis. Curr Opin Neurol 31(5):640\u2013647. https:\/\/doi.org\/10.1097\/wco.0000000000000593","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"10068_CR51","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","volume":"19","author":"M Wong","year":"2010","unstructured":"Wong M, Martin LJ (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 19(11):2284\u20132302. https:\/\/doi.org\/10.1093\/hmg\/ddq106","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10068_CR52","doi-asserted-by":"publisher","first-page":"e94496","DOI":"10.1371\/journal.pone.0094496","volume":"9","author":"S Xie","year":"2014","unstructured":"Xie S, Chen M, Yan B, He X, Chen X, Li D (2014) Identification of a role for the PI3K\/AKT\/mTOR signaling pathway in innate immune cells. PLoS ONE 9(4):e94496. https:\/\/doi.org\/10.1371\/journal.pone.0094496","journal-title":"PLoS ONE"},{"issue":"5","key":"10068_CR53","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1021\/acschemneuro.8b00704","volume":"10","author":"B Xu","year":"2019","unstructured":"Xu B, Zheng C, Chen X, Zhang Z, Liu J, Spencer P, Yang X (2019) Dysregulation of myosin complex and striated muscle contraction pathway in the brains of ALS-SOD1 model mice. ACS Chem Neurosci 10(5):2408\u20132417. https:\/\/doi.org\/10.1021\/acschemneuro.8b00704","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10068_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F, Na L, Li Y, Chen L (2020a) Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell & Bioscience 10(1):54. 10.1186\/s13578-020-00416-0","journal-title":"Cell & Bioscience"},{"key":"10068_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F, Na L, Li Y, Chen L (2020b) Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 10:54. 10.1186\/s13578-020-00416-0","journal-title":"Cell Biosci"},{"key":"10068_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.mcn.2015.08.009","volume":"68","author":"X Yin","year":"2015","unstructured":"Yin X, Ren M, Jiang H, Cui S, Wang S, Jiang H, Feng H (2015) Downregulated AEG-1 together with inhibited PI3K\/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol Cell Neurosci 68:303\u2013313. https:\/\/doi.org\/10.1016\/j.mcn.2015.08.009","journal-title":"Mol Cell Neurosci"},{"key":"10068_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https:\/\/doi.org\/10.4103\/2152-7806.169561","journal-title":"Surg Neurol Int"},{"key":"10068_CR58","doi-asserted-by":"publisher","first-page":"174480691983024","DOI":"10.1177\/1744806919830240","volume":"15","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang L, Wang H, Su Z, Pang X (2019) Neuroinflammation and central PI3K\/Akt\/mTOR signal pathway contribute to bone cancer pain. Mol Pain 15:1744806919830240. https:\/\/doi.org\/10.1177\/1744806919830240","journal-title":"Mol Pain"},{"issue":"4","key":"10068_CR59","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Beers DR, Appel SH (2013) Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 8(4):888\u2013899","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"10068_CR60","doi-asserted-by":"publisher","first-page":"e01131","DOI":"10.1002\/brb3.1131","volume":"8","author":"S Zhou","year":"2018","unstructured":"Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D (2018) Amyotrophic lateral sclerosis in Beijing: epidemiologic features and prognosis from 2010 to 2015. Brain Behav 8(11):e01131. https:\/\/doi.org\/10.1002\/brb3.1131","journal-title":"Brain Behav"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-023-10068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-023-10068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-023-10068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:11:33Z","timestamp":1697422293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-023-10068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10068"],"URL":"https:\/\/doi.org\/10.1007\/s11481-023-10068-9","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were carried out according to the protocols approved by the Institutional Animal Care and Use Committee (Ethical Committee Approval number: R2018020) of Peking University Shenzhen Graduate School.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}